Models

50
20
10

Submission ID	Name	Format	Submitter	Submitted	Modified	Certification
DDMODEL00000094	Insulin sensitivity from labeled IVGTT	PharmML	Roberto Bizzotto	2015/12/10	2016/05/18
DDMODEL00000213	Li_2006_PK_Meropenem_AdultPatients	PharmML	Lisa Ehmann	2016/08/26	2016/08/30
DDMODEL00000195	Sibrotuzumab_PK_Carcinoma	PharmML	Niklas Hartung	2016/05/31	2016/07/15
DDMODEL00000132	Minimal model	PharmML	Roberto Bizzotto	2015/12/29	2016/05/18
DDMODEL00000229	A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML)	PharmML	Moran Optimata	2016/10/26	2016/11/01
DDMODEL00000103	Trefz_2015_metabolism_Kuvan_TurnoverKPD	PharmML	Nadia Terranova	2015/12/11	2016/07/18
DDMODEL00000090	Claret_2009_oncology_capecitabine_TGI	PharmML	Nadia Terranova	2015/12/10	2016/07/13
DDMODEL00000128	Ribba_2012_PCV	PharmML	Christian Laveille	2015/12/15	2015/12/16
DDMODEL00000078	Chalret_2014_Abexinostat	PharmML	Vincent Croixmarie	2015/12/09	2016/02/12
DDMODEL00000230	A pharmacokinetic model for interleukin-21 therapy validated prospectively in murine experiments in melanoma	PharmML	Moran Optimata	2016/10/26	2016/11/01

Showing 111 to 120 of 151 models

First

12 13 14 15 16

Last

Help